We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu
Trial record 29 of 139 for:    Back Pain | First posted from 03/01/2013 to 11/08/2013

Mindful Walking in Low Back Pain (MW-LBP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01893073
Recruitment Status : Completed
First Posted : July 8, 2013
Last Update Posted : March 26, 2014
Information provided by (Responsible Party):
Benno Brinkhaus, Charite University, Berlin, Germany

Brief Summary:
The purpose of this study is to determine whether a mindful walking program is effective in the treatment of patients with chronic low back pain.

Condition or disease Intervention/treatment Phase
Chronic Low Back Pain Behavioral: Mindful walking program Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 48 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effectiveness of a a Mindful Walking Program in Patients With Chronic Low Back Pain - a Randomized Controlled Trial
Study Start Date : June 2013
Actual Primary Completion Date : March 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Back Pain

Arm Intervention/treatment
Active Comparator: Mindful walking
A weekly 60 minutes walking group exercise program consisting of a combination of walking and mindfulness over 8 weeks.
Behavioral: Mindful walking program
No Intervention: Waiting group

Primary Outcome Measures :
  1. Pain intensity on visual analogue scale [ Time Frame: 8 weeks ]

Secondary Outcome Measures :
  1. Back function - FFbH-R-Questionnaire [ Time Frame: 8 weeks, 12 weeks ]
  2. Pain intensity on visual analogue scale [ Time Frame: 12 weeks ]
  3. Cohens perceived stress scale [ Time Frame: 8 weeks, 12 weeks ]
  4. Quality of Life - SF 36 [ Time Frame: 8 weeks, 12 weeks ]
  5. Intake of paracetamol [ Time Frame: 8 weeks ]
  6. Adverse events [ Time Frame: 8 weeks, 12 weeks ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • male and female, 18-65 years
  • chronic low back pain (disease duration > 3 months)
  • pain intensity on visual analogue scale at inclusion > 40 mm (0-100 mm scale)
  • only pharmacological treatment with NSAID or no treatment in the last 4 weeks
  • undersigned informed consent form

Exclusion Criteria:

  • active walking or jogging in the last 6 weeks (< 60 minutes/week)
  • regular meditation, relaxation exercise, mindfulness exercise in last 6 weeks (> 30 minutes per week)
  • use of complementary medicine therapies as acupuncture, homeopathy, herbal medicine in last 6 weeks or planned in the next 12 weeks
  • use of other nonpharmacological therapies as physical therapy, manual therapy or osteopathy in the last 4 weeks
  • participation in another trials within the last 3 months
  • pathological neurological symptoms such as muscular paralysis or paraesthesia due to spinal disc herniation or other causes
  • risk of falls and inability to walk
  • angina pectoris in the last 3 months
  • chronic respiratory disease with respiratory insufficiency
  • intake of central nervous system-acting analgesics in the last 6 weeks
  • Known renal and / or hepatic diseases
  • Severe organic, psychological or psychiatric disorders that are not permitting a study participation
  • applying for early retirement due to low back pain
  • no undersigned informed consent form

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01893073

Layout table for location information
Institute for Social Medicine, Epidemiology and Health Economics, Charité Universitätsmedizin Berlin, Germany
Berlin, Germany, 10117
Sponsors and Collaborators
Charite University, Berlin, Germany
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Benno Brinkhaus, Professor, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT01893073    
Other Study ID Numbers: MW-LBP
First Posted: July 8, 2013    Key Record Dates
Last Update Posted: March 26, 2014
Last Verified: March 2014
Additional relevant MeSH terms:
Layout table for MeSH terms
Back Pain
Low Back Pain
Neurologic Manifestations